Unknown

Dataset Information

0

The economics of medicines optimization: policy developments, remaining challenges and research priorities.


ABSTRACT:

Background

This review scopes the evidence on the effectiveness and cost-effectiveness of interventions to improve suboptimal use of medicines in order to determine the evidence gaps and help inform research priorities.

Sources of data

Systematic searches of the National Health Service (NHS) Economic Evaluation Database, the Cochrane Database of Systematic Reviews and the Database of Abstracts of Reviews of Effects.

Areas of agreement

The majority of the studies evaluated interventions to improve adherence, inappropriate prescribing and prescribing errors.

Areas of controversy

Interventions tend to be specific to a particular stage of the pathway and/or to a particular disease and have mostly been evaluated for their effect on intermediate or process outcomes.

Growing points

Medicines optimization offers an opportunity to improve health outcomes and efficiency of healthcare.

Areas timely for developing research

The available evidence is insufficient to assess the effectiveness and cost-effectiveness of interventions to address suboptimal medicine use in the UK NHS. Decision modelling, evidence synthesis and elicitation have the potential to address the evidence gaps and help prioritize research.

SUBMITTER: Faria R 

PROVIDER: S-EPMC4154397 | biostudies-literature | 2014 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

The economics of medicines optimization: policy developments, remaining challenges and research priorities.

Faria Rita R   Barbieri Marco M   Light Kate K   Elliott Rachel A RA   Sculpher Mark M  

British medical bulletin 20140901 1


<h4>Background</h4>This review scopes the evidence on the effectiveness and cost-effectiveness of interventions to improve suboptimal use of medicines in order to determine the evidence gaps and help inform research priorities.<h4>Sources of data</h4>Systematic searches of the National Health Service (NHS) Economic Evaluation Database, the Cochrane Database of Systematic Reviews and the Database of Abstracts of Reviews of Effects.<h4>Areas of agreement</h4>The majority of the studies evaluated i  ...[more]

Similar Datasets

| S-EPMC10195557 | biostudies-literature
| S-EPMC4895878 | biostudies-other
| S-EPMC7488309 | biostudies-literature
| S-EPMC8033370 | biostudies-literature
| S-EPMC5075982 | biostudies-other
| S-EPMC6248267 | biostudies-literature
| S-EPMC8106069 | biostudies-literature
| S-EPMC6161373 | biostudies-literature
| S-EPMC9754238 | biostudies-literature
| S-EPMC7528944 | biostudies-literature